MX2014013696A - Derivado de pirazol y uso del mismo para propositos medicos. - Google Patents
Derivado de pirazol y uso del mismo para propositos medicos.Info
- Publication number
- MX2014013696A MX2014013696A MX2014013696A MX2014013696A MX2014013696A MX 2014013696 A MX2014013696 A MX 2014013696A MX 2014013696 A MX2014013696 A MX 2014013696A MX 2014013696 A MX2014013696 A MX 2014013696A MX 2014013696 A MX2014013696 A MX 2014013696A
- Authority
- MX
- Mexico
- Prior art keywords
- pyrazole derivative
- medical purposes
- present
- constipation
- prevention
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención proporciona derivados de pirazol, usos de los mismos para los propósitos médicos y similares. Más particularmente, la presente invención se refiere a productos farmacéuticos útiles para la prevención o el tratamiento del estreñimiento, que comprenden como un ingrediente activo 3-(3-{4-[3-(ß-D-glucopiranosiloxi)-5-isopropil-1H-pirazol-4-ilmet il]-3-metilfenoxi}propilamino)-2,2-dimetiIpropionamida, o una sal farmacéuticamente aceptable del mismo. Los productos farmacéuticos de la presente invención ejercen un efecto de aumentar la frecuencia o la defecación o similares, y son útiles para la prevención o el tratamiento del estreñimiento.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012105847 | 2012-05-07 | ||
| PCT/JP2013/062755 WO2013168671A1 (ja) | 2012-05-07 | 2013-05-02 | ピラゾール誘導体及びその医薬用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2014013696A true MX2014013696A (es) | 2015-02-05 |
| MX359988B MX359988B (es) | 2018-10-18 |
Family
ID=49550709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014013696A MX359988B (es) | 2012-05-07 | 2013-05-02 | Derivado de pirazol y uso del mismo para propósitos médicos. |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US9273085B2 (es) |
| EP (1) | EP2848254B1 (es) |
| JP (2) | JP5663699B2 (es) |
| KR (1) | KR101868991B1 (es) |
| CN (1) | CN104284665B (es) |
| AU (1) | AU2013258566B2 (es) |
| BR (1) | BR112014027841B1 (es) |
| CA (1) | CA2872002C (es) |
| DK (1) | DK2848254T3 (es) |
| ES (1) | ES2601127T3 (es) |
| HK (1) | HK1204773A1 (es) |
| MX (1) | MX359988B (es) |
| PL (1) | PL2848254T3 (es) |
| PT (1) | PT2848254T (es) |
| RU (1) | RU2602739C2 (es) |
| WO (1) | WO2013168671A1 (es) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5889321B2 (ja) | 2010-11-04 | 2016-03-22 | アルビレオ アクチエボラグ | 肝疾患の処置用のｉｂａｔ阻害剤 |
| PT2848254T (pt) * | 2012-05-07 | 2016-10-05 | Kissei Pharmaceutical | Derivado de pirazol e utilização do mesmo para propósitos médicos |
| MX346453B (es) | 2013-02-04 | 2017-03-17 | Taisho Pharmaceutical Co Ltd | Medicamento profilactico o terapeutico para el estreñimiento. |
| KR102296314B1 (ko) * | 2014-06-25 | 2021-09-01 | 이에이 파마 가부시키가이샤 | 고형 제제 및 그의 안정화 방법 |
| JP6751020B2 (ja) | 2014-06-25 | 2020-09-02 | Ｅａファーマ株式会社 | 固形製剤及びその着色防止又は着色低減方法 |
| EP3773546A4 (en) | 2018-03-28 | 2022-02-23 | Avolynt | METHODS OF TREATMENT OF POST-PRRANDIAL HYPOGLYCEMIA |
| CN112449637B (zh) | 2018-06-05 | 2024-03-19 | 阿尔比里奥公司 | 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途 |
| MX2020013839A (es) | 2018-06-20 | 2021-03-25 | Albireo Ab | Formulacion farmaceutica de odevixibat. |
| US11801226B2 (en) | 2018-06-20 | 2023-10-31 | Albireo Ab | Pharmaceutical formulation of odevixibat |
| US11007142B2 (en) | 2018-08-09 | 2021-05-18 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US11549878B2 (en) | 2018-08-09 | 2023-01-10 | Albireo Ab | In vitro method for determining the adsorbing capacity of an insoluble adsorbant |
| US10975045B2 (en) | 2019-02-06 | 2021-04-13 | Aibireo AB | Benzothiazepine compounds and their use as bile acid modulators |
| PT3921028T (pt) | 2019-02-06 | 2023-02-15 | Albireo Ab | Compostos de benzotiadiazepina e a sua utilização como moduladores de ácido biliar |
| US10941127B2 (en) | 2019-02-06 | 2021-03-09 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
| EP4069361B1 (en) | 2019-12-04 | 2024-01-03 | Albireo AB | Benzothia(di)azepine compounds and their use as bile acid modulators |
| US11014898B1 (en) | 2020-12-04 | 2021-05-25 | Albireo Ab | Benzothiazepine compounds and their use as bile acid modulators |
| CA3158276A1 (en) | 2019-12-04 | 2021-06-10 | Per-Goran Gillberg | Benzothia(di)azepine compounds and their use as bile acid modulators |
| CN114761018A (zh) | 2019-12-04 | 2022-07-15 | 阿尔比里奥公司 | 苯并硫杂二氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途 |
| CR20220315A (es) | 2019-12-04 | 2022-10-26 | Albireo Ab | Compuestos de benzoti(di)azepina y su uso como moduladores del ácido biliar |
| ES3002777T3 (en) | 2020-08-03 | 2025-03-07 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| KR20230106651A (ko) | 2020-11-12 | 2023-07-13 | 알비레오 에이비 | 진행성 가족성 간내 담즙정체증(pfic)을 치료하기 위한 오데빅시바트 |
| JP2024500309A (ja) | 2020-12-04 | 2024-01-09 | アルビレオ エービー | ベンゾチア（ジ）アゼピン化合物および胆汁酸モジュレータとしてのその使用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004137245A (ja) | 2002-08-23 | 2004-05-13 | Kissei Pharmaceut Co Ltd | ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体 |
| US7846929B2 (en) * | 2006-04-26 | 2010-12-07 | Genentech, Inc. | Phosphoinositide 3-kinase inhibitor compounds and methods of use |
| CA2709530C (en) * | 2007-12-27 | 2016-02-23 | Kissei Pharmaceutical Co., Ltd. | Monosebacate of pyrazole derivative |
| US8354382B2 (en) | 2008-04-16 | 2013-01-15 | Kissei Pharmaceutical Co., Ltd. | Hemifumarate of a pyrazole derivative |
| AR087701A1 (es) | 2011-08-31 | 2014-04-09 | Japan Tobacco Inc | Derivados de pirazol con actividad inhibidora de sglt1 |
| PT2848254T (pt) * | 2012-05-07 | 2016-10-05 | Kissei Pharmaceutical | Derivado de pirazol e utilização do mesmo para propósitos médicos |
-
2013
- 2013-05-02 PT PT137877148T patent/PT2848254T/pt unknown
- 2013-05-02 JP JP2014514708A patent/JP5663699B2/ja active Active
- 2013-05-02 AU AU2013258566A patent/AU2013258566B2/en active Active
- 2013-05-02 RU RU2014149181/15A patent/RU2602739C2/ru active
- 2013-05-02 ES ES13787714.8T patent/ES2601127T3/es active Active
- 2013-05-02 DK DK13787714.8T patent/DK2848254T3/en active
- 2013-05-02 KR KR1020147033887A patent/KR101868991B1/ko active Active
- 2013-05-02 MX MX2014013696A patent/MX359988B/es active IP Right Grant
- 2013-05-02 CN CN201380024202.3A patent/CN104284665B/zh active Active
- 2013-05-02 WO PCT/JP2013/062755 patent/WO2013168671A1/ja active Application Filing
- 2013-05-02 PL PL13787714T patent/PL2848254T3/pl unknown
- 2013-05-02 CA CA2872002A patent/CA2872002C/en active Active
- 2013-05-02 US US14/399,093 patent/US9273085B2/en active Active
- 2013-05-02 BR BR112014027841-5A patent/BR112014027841B1/pt active IP Right Grant
- 2013-05-02 EP EP13787714.8A patent/EP2848254B1/en active Active
-
2014
- 2014-12-04 JP JP2014245645A patent/JP6105546B2/ja active Active
-
2015
- 2015-06-05 HK HK15105374.8A patent/HK1204773A1/xx unknown
-
2016
- 2016-01-14 US US14/995,489 patent/US9694027B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR20150013671A (ko) | 2015-02-05 |
| BR112014027841B1 (pt) | 2022-08-09 |
| RU2014149181A (ru) | 2016-06-27 |
| CA2872002A1 (en) | 2013-11-14 |
| AU2013258566B2 (en) | 2017-03-16 |
| PL2848254T3 (pl) | 2017-03-31 |
| EP2848254A1 (en) | 2015-03-18 |
| US9694027B2 (en) | 2017-07-04 |
| EP2848254B1 (en) | 2016-08-03 |
| WO2013168671A1 (ja) | 2013-11-14 |
| RU2602739C2 (ru) | 2016-11-20 |
| JP5663699B2 (ja) | 2015-02-04 |
| US20160129031A1 (en) | 2016-05-12 |
| CN104284665A (zh) | 2015-01-14 |
| KR101868991B1 (ko) | 2018-06-19 |
| EP2848254A4 (en) | 2015-07-15 |
| CN104284665B (zh) | 2016-11-16 |
| JPWO2013168671A1 (ja) | 2016-01-07 |
| AU2013258566A1 (en) | 2014-11-27 |
| CA2872002C (en) | 2019-01-15 |
| MX359988B (es) | 2018-10-18 |
| US9273085B2 (en) | 2016-03-01 |
| US20150141631A1 (en) | 2015-05-21 |
| JP2015083580A (ja) | 2015-04-30 |
| DK2848254T3 (en) | 2016-10-31 |
| PT2848254T (pt) | 2016-10-05 |
| ES2601127T3 (es) | 2017-02-14 |
| HK1204773A1 (en) | 2015-12-04 |
| JP6105546B2 (ja) | 2017-03-29 |
| BR112014027841A2 (pt) | 2017-06-27 |
| BR112014027841A8 (pt) | 2021-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2014013696A (es) | Derivado de pirazol y uso del mismo para propositos medicos. | |
| NZ602510A (en) | Treatment of lupus nephritis using laquinimod | |
| MX2016013529A (es) | Derivados de amidas y sales farmaceuticamente aceptables de los mismos, método de preparación de los mismos y aplicación médica de los mismos. | |
| NZ612000A (en) | Bicyclo[3.2.1]octyl amide derivatives and uses of same | |
| CR20200286A (es) | DERIVADOS DE DIHIDRO-BENZO-OXAZINA Y DIHIDRO-PIRIDO-OXAZINA (Divisional 2014-0294) | |
| MX2014000341A (es) | Novedosos derivados de trifluoro-metil-oxadiazol y su uso en el tratamiento de enfermedades. | |
| EA201590450A1 (ru) | Сульфамоил-ариламиды и их применение в качестве лекарственных препаратов для лечения гепатита b | |
| EA201592250A1 (ru) | Пиразолопирролидиновые производные и их применение в лечение заболеваний | |
| MX2015008957A (es) | Fluoro-[1,3]oxazinas como inhibidores de beta-secretasa 1 (bace1). | |
| EA201592256A1 (ru) | Производные имидазопирролидинона и их применение при лечении заболеваний | |
| WO2011107608A8 (en) | Heterocyclic amides as rock inhibitors | |
| MX2014003408A (es) | N-(3-(2-amino-6,6-difluor-4,4a,5,6,7,7a-hexahidro-ciclopenta-[e][ 1,3]oxazin-4-il)-fenil)-amidas como inhibidores de la beta-secretasa 1 (bace1). | |
| UA113538C2 (xx) | Фторметил-5,6-дигідро-4h-$1,3]оксазини | |
| MX2013008056A (es) | 1,4-oxazepinas como inhibidores de beta-secretasa 1 (bace1) y/o beta-secretasa 2 (bace2). | |
| MY169485A (en) | Heterocyclic compounds suitable for the treatment of dyslipidemia | |
| NZ628408A (en) | Ingenol derivatives in reactivation of latent hiv virus | |
| EA201400067A1 (ru) | Новая терапевтическая композиция, содержащая апоморфин в качестве активного ингредиента | |
| TN2012000092A1 (en) | Therapeutic agent for mood disorders | |
| EA201500513A1 (ru) | Продукт сомикронизации, включающий ацетат улипристала | |
| MX362830B (es) | Agente terapeutico o profilactico para enfermedades del tracto biliar. | |
| EA201691058A1 (ru) | Производные пирролопирролона и их применение для лечения заболеваний | |
| UA107702C2 (xx) | Похідні бензаміду | |
| MY169266A (en) | Solid state forms of n-((s)-2,3-dihydroxy-propyl)-3-(2-fluoro-4-iodo-phenylamino)-isonicotinamide | |
| TN2012000093A1 (en) | Therapeutic agent for anxiety disorders | |
| MX2010008586A (es) | Amidas de acido 3-(4-fluorofenil)-3-hidroxi-2-amino-propionico y compuestos relacionados que tienen actividad analgesica. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |